Share on LinkedInShare on LinkedIn

ARTICLE · 08 FEBRUARY 2024

Market Intelligence Thought Leadership Award Winner

Norwich Pharmacal Orders In Ireland: Helpful Clarity From The Irish Courts

Two judgments handed down by the High Court and Court of Appeal, respectively, in late 2023 helpfully summarise the current scope of the Norwich Pharmacal jurisdiction in Ireland.

IrelandLitigation, Mediation & Arbitration

Two judgments handed down by the High Court and Court of Appeal, respectively, in late 2023 helpfully summarise the current scope of the Norwich Pharmacal jurisdiction in Ireland.

In particular, the Court of Appeal took the opportunity to review the development of the jurisdiction in Ireland and, cognisant of the "significant debate (and attendant uncertainty)", provided a very useful summary of the Irish position, which differs to other common law jurisdictions.

While the Court of Appeal confirmed that Norwich Pharmacal relief is exceptional, it deemed the test set out in Salesian Secondary College [2021] IEHC 287 that the plaintiff must establish "very clear proof" to be too high a barrier. However, the Court of Appeal did not accept that the position in Ireland was the same as that in England and Wales (i.e. that the plaintiff must simply demonstrate a "good arguable case" against the alleged wrongdoer) and instead confirmed that appropriate test in Ireland

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from